Effects of Intravenous Nifekalant, A Class III Antiarrhythmic Drug, on Atrial Vulnerability Parameters in Patients with Paroxysmal Atrial Fibrillation

2004 ◽  
Vol 27 (2) ◽  
pp. 212-217 ◽  
Author(s):  
TAKAKO MINAMI ◽  
SHOJIRO ISOMOTO ◽  
KOJIRO NAKAO ◽  
NORIHIRO KOMIYA ◽  
SATOKI FUKAE ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Paroxysmal Atrial Fibrillation ◽  
Class Iii ◽  
Class Iii Antiarrhythmic Drug ◽  
Atrial Vulnerability

Bepridil Prevents Paroxysmal Atrial Fibrillation by a Class III Antiarrhythmic Drug Effect

2003 ◽  
Vol 26 (1p2) ◽  
pp. 314-317 ◽  
Author(s):  
TORU YOSHIDA ◽  
SHINICHI NIWANO ◽  
KIMIATSU INUO ◽  
JUNKO SAITO ◽  
JISHO KOJIMA ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Paroxysmal Atrial Fibrillation ◽  
Drug Effect ◽  
Class Iii ◽  
Class Iii Antiarrhythmic Drug

Effects of a New Class III Antiarrhythmic Drug Nibentan in a Canine Model of Vagally Mediated Atrial Fibrillation

2000 ◽  
Vol 36 (1) ◽  
pp. 77-89 ◽  
Author(s):  
Vadim V. Fedorov ◽  
Oleg F. Sharifov ◽  
Galina G. Beloshapko ◽  
Anna V. Yushmanova ◽  
Leonid V. Rosenshtraukh
Keyword(s):  
Atrial Fibrillation ◽  
Antiarrhythmic Drug ◽  
Canine Model ◽  
Class Iii ◽  
New Class ◽  
Class Iii Antiarrhythmic Drug

scholarly journals Clinical Efficacy of Bepridil for Class I Antiarrhythmic Drug-Induced Atrial Flutter in Patients with Paroxysmal Atrial Fibrillation

2008 ◽  
Vol 24 (2) ◽  
pp. 71-75
Author(s):  
Hidemori Hayashi ◽  
Masataka Sumiyoshi ◽  
Satoru Suwa ◽  
Hidehiko Sakurai ◽  
Yasunobu Kawano ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Atrial Flutter ◽  
Clinical Efficacy ◽  
Antiarrhythmic Drug ◽  
Paroxysmal Atrial Fibrillation ◽  
Class I ◽  
Drug Induced ◽  
Class I Antiarrhythmic Drug
Sign in / Sign up

Export Citation Format

Share Document